Biotechnology in Europe industry profile is an essential resource for top-level data and analysis covering the biotechnology industry. It includes detailed data on market size and segmentation, plus textual and graphical analysis of the key trends and competitive landscape, leading companies and demographic information.

Scope

* Contains an executive summary and data on value, volume and/or segmentation

* Provides textual analysis of the industry’s recent performance and future prospects

* Incorporates in-depth five forces competitive environment analysis and scorecards

* Includes a five-year forecast of the industry

* The leading companies are profiled with supporting key financial metrics

* Supported by the key macroeconomic and demographic data affecting the market

Highlights

* Detailed information is included on market size, measured by value and/or volume

* Five forces scorecards provide an accessible yet in depth view of the market’s competitive landscape

Why you should buy this report

* Spot future trends and developments

* Inform your business decisions

* Add weight to presentations and marketing materials

* Save time carrying out entry-level research

Market Definition

The biotechnology market consists of the development, manufacturing and marketing of products based on advanced biotechnology research. The market value reflects revenues of companies within this industry from product sales, licensing fees, royalties and research funding. Any currency conversions used in the creation of this report have been calculated using constant 2007 annual average exchange rates.

For the purpose of this report the Americas comprises Brazil, Canada, Mexico and the US.

Europe comprises Belgium, the Czech Republic, Denmark, France, Germany, Hungary, Italy, Netherlands, Norway, Poland, Russia, Spain, Sweden and the UK.

Asia-Pacific comprises Australia, China, Japan, India, Singapore, South Korea and Taiwan.

The global figure comprises the Americas, Asia-Pacific and Europe. 

EXECUTIVE SUMMARY 3
CHAPTER 1 Market Overview 7
1.1 Market Definition 7
1.2 Research Highlights 7
1.3 Market Analysis 8
CHAPTER 2 Market Value 9
CHAPTER 3 Market Segmentation I 10
CHAPTER 4 Market Segmentation II 11
CHAPTER 5 Five Forces Analysis 12
5.1 Summary 12
5.2 Buyer Power 13
5.3 Supplier Power 14
5.4 New Entrants 15
5.5 Rivalry 17
CHAPTER 6 Leading Companies 18
6.1 UCB Group 18
6.2 Merck KGaA 21
6.3 Innogenetics N V 23
6.4 Amgen Inc. 26
CHAPTER 7 Market Forecasts 28
7.1 Market Value Forecast 28
CHAPTER 8 Demographics 29
CHAPTER 9 Appendix 30
9.1 Methodology 30

LIST OF TABLES
Table 1: Europe Biotechnology Market Value: $ million, 2003-2007 9
Table 2: Europe Biotechnology Market Segmentation I: % Share, by Value, 2007 10
Table 3: Europe Biotechnology Market Segmentation II: % Share, by Value, 2007 11
Table 1: Key Facts: UCB Group 18
Table 1: Key Financials: UCB Group 20
Table 2: Key Facts: Merck KGaA 21
Table 3: Key Financials: Merck KGaA 22
Table 4: Key Facts: Innogenetics N V 23
Table 5: Key Financials: Innogenetics N V 25
Table 6: Key Facts: Amgen Inc. 26
Table 7: Key Financials: Amgen Inc. 27
Table 8: Europe Biotechnology Market Value Forecast: $ million, 2007-2012 28
Table 9: Europe Exchange Rate, 2003 29